Corporate Officers
Henri A. Termeer
Chairman, President and Chief Executive Officer
Mark R. Bamforth
Senior Vice President, Corporate Operations and Pharmaceuticals
John Butler
Senior Vice President; President, Renal, Endocrinology & Cardiovascular
Earl M. Collier, Jr., Esquire
Executive Vice President
Zoltan Csimma
Senior Vice President, Chief Human Resources Officer
Thomas J. DesRosier, Esquire
Senior Vice President; General Counsel; Chief Legal Officer
Richard H. Douglas, Ph.D.
Senior Vice President, Corporate Development
Mark J. Enyedy
Senior Vice President; President, Oncology & Multiple Sclerosis
David D. Fleming
Group Senior Vice President
James A. Geraghty
Senior Vice President
James Kean
Corporate Controller
Alison Lawton
Senior Vice President; Global Product Access, Quality Systems & Regulatory Affairs
Roger W. Louis, Esquire
Chief Compliance Officer
Mary McGrane
Vice President; Senior Vice President, Government Relations
John M. McPherson, Ph.D.
Senior Vice President, Head of Biologics Research and Development
David Meeker, M.D.
Executive Vice President, Therapeutics, Biosurgery & Transplant
C. Ann Merrifield
Senior Vice President; President, Genzyme Biosurgery
Richard A. Moscicki, M.D.
Senior Vice President, Biomedical & Regulatory Affairs; Chief Medical Officer
Donald E. Pogorzelski
Vice President; President, Diagnostic Products
Alan E. Smith, Ph.D.
Senior Vice President, Research; Chief Scientific Officer
Sandford D. Smith
Executive Vice President; President, International Group
Gail F. Sullivan
Vice President and Treasurer
Peter Wirth, Esquire
Executive Vice President, Legal and Corporate Development; Secretary
Michael S. Wyzga
Executive Vice President, Finance; Chief Financial Officer; Chief Accounting Officer
|
Home
